PAREXEL International to Present at UBS Healthcare Conference

BOSTON–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL) announced today that it
will be presenting at the UBS Healthcare Conference on Tuesday, May 24,
2016, in New York City. Ingo Bank, Senior Vice President and Chief
Financial Officer will be making a presentation on PAREXEL and
discussing business developments at 8:30 a.m. ET.

A live webcast of the presentation will be available through the “Investors”
section of PAREXEL’s website at www.PAREXEL.com
in the Upcoming Events portion of the main page, and a replay of the
presentation will be available on the website for 90 days after the
presentation.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical
services company, providing a broad range of expertise-based clinical
research, consulting, medical communications, and technology solutions
and services to the worldwide pharmaceutical, biotechnology and medical
device industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to clinical
pharmacology, clinical trials management, and reimbursement. PAREXEL
Informatics provides advanced technology solutions, including medical
imaging, to facilitate the clinical development process. Headquartered
near Boston, Massachusetts, PAREXEL has offices in 82 locations in 51
countries around the world, and had approximately 18,450 employees in
the third quarter. For more information about PAREXEL International,
visit www.PAREXEL.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160509005070/en/